In response to the continued rise in syphilis and congenital syphilis circumstances seen throughout the state, the North Carolina Division of Well being and Human Companies will enhance entry to therapy.
Why it issues: Early syphilis circumstances elevated in 2022 by 631% in comparison with 2012, in response to a truth sheet from the North Carolina Division of Well being and Human Companies.
North Carolina Medicaid will now cowl a further therapy for syphilis and congenital syphilis, Extencilline, to handle the continued nationwide scarcity of Penicillin G Benzathine, the first-line therapy for syphilis.
In 2022, North Carolina had 4,123 circumstances of early syphilis, greater than doubling since 2018, in response to a press launch from the North Carolina Division of Well being and Human Companies, and has seen a rise in congenital syphilis infections, from 1 case in 2012 to 57 circumstances in 2022.
“Congenital syphilis infections are the very best they’ve been in nearly 20 years, resulting in lifelong well being impacts and toddler deaths. We’ve to behave now to fight this disaster as syphilis and congenital syphilis are preventable,” State Well being Director and North Carolina Division of Well being and Human Companies Chief Medical Officer Dr. Elizabeth Cuervo Tilson stated in an announcement.
